Amarin Supported Peer Reviewed Articles EPA Research, Case Studies, Overviews
Elevated triglycerides (≥150 mg/dL) and high triglycerides (200–499 mg/dL) are significant predictors of new heart failure diagnosis: A real-world analysis of high-risk statin-treated patients.
Residual Hypertriglyceridemia and Estimated Atherosclerotic Cardiovascular Disease Risk By Statin Use In U.S. Adults With Diabetes
Does High-Dose Fish Oil Reduce Cardiovascular Events Via Triglycerides?
Prevalence Of Hypertriglyceridaemia In Statin Treated Very High-Risk Patients Who Might Benefit From Treatment With Icosapent Ethyl For Secondary Prevention In Clinical Practice–Results Of DYSIS.
Association of elevated triglycerides with increased cardiovascular risk and direct costs in statin-treated patients
Hypertriglyceridemia is associated with an increased risk of peripheral arterial revascularization in high-risk statin-treated patients: A large administrative retrospective analysis.
The Economic Burden of Hypertriglyceridemia Among US Adults With Diabetes or Atherosclerotic Cardiovascular Disease on Statin Therapy
The eicosapentaenoic acid:arachidonic acid ratio and its clinical utility in cardiovascular disease.